Nrf2 and the promotion of atherosclerosis:lessons to be learned

Bibliography

• Lusis AJ. Atherosclerosis. Nature 407(6801), 233–241 (2000).
   Google Scholar
• Araujo J. Particulate air pollution, systemic oxidative stress, inflammation, and atherosclerosis. Air Qual. Atmos. Health 4(1), 79–93 (2012).
   Google Scholar
• Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol. Rev. 84(4), 1381–1478 (2004).
   Google Scholar
• Barry-Lane PA, Patterson C, van der Merwe M et al. p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. J. Clin. Invest. 108(10), 1513–1522 (2001).
   Google Scholar
• Yet SF, Layne MD, Liu X et al. Absence of heme oxygenase‒1 exacerbates atherosclerotic lesion formation and vascular remodeling. FASEB J. 17(12), 1759–1761 (2003).
   Google Scholar
• Ishikawa K, Sugawara D, Wang XP et al. Heme oxygenase‒1 inhibits atherosclerotic lesion formation in LDL-receptor knockout mice. Circ. Res. 88(5), 506–512 (2001).
   Google Scholar
• Araujo JA, Meng L, Tward AD et al. Systemic rather than local heme oxygenase‒1 overexpression improves cardiac allograft outcomes in a new transgenic mouse. J. Immunol. 171(3), 1572–1580 (2003).
   Google Scholar
• Tsuchihashi S, Livhits M, Zhai Y, Busutill RW, Araujo JA, Kupiec-Weglinski JW. Basal rather than induced heme oxygenase‒1 levels are crucial in the antioxidant cytoprotection. J. Immunol. 177(7), 4749–4757 (2006).
   Google Scholar
• Lewis P, Stefanovic N, Pete J et al. Lack of the antioxidant enzyme glutathione peroxidase‒1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice. Circulation 115(16), 2178–2187 (2007).
   Google Scholar
• Rimm EB, Stampfer MJ. Antioxidants for vascular disease. Med. Clin. North Am. 84(1), 239–249 (2000).
   Google Scholar
• Meagher E, Rader DJ. Antioxidant therapy and atherosclerosis: animal and human studies. Trends Cardiovasc. Med. 11(3–4), 162–165 (2001).
   Google Scholar
• Steinhubl SR. Why have antioxidants failed in clinical trials? Am. J. Cardiol. 101(10A), 14D–19D (2008).
   Google Scholar
• Itoh K, Chiba T, Takahashi S et al. An Nrf2/ small Maf heterodimer mediates the induction of phase 2 detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 236(2), 313–322 (1997).
   Google Scholar
• Fahey JW, Haristoy X, Dolan PM et al. Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a] pyrene-induced stomach tumors. Proc. Natl Acad. Sci. USA 99(11), 7610–7615 (2002).
   Google Scholar
• Morimitsu Y, Nakagawa Y, Hayashi K et al. A sulforaphane analogue that potently activates the Nrf2-dependent detoxification pathway. J. Biol. Chem. 277(5), 3456–3463 (2002).
   Google Scholar
• Balogun E, Hogue M, Gong P et al. Curcumin activates the haem oxygenase‒1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem. J. 371(Pt 3), 887–895 (2003).
   Google Scholar
• Motohashi H, Yamamoto M. Nrf2–Keap1 defines a physiologically important stress response mechanism. Trends Mol. Med. 10(11), 549–557 (2004).
   Google Scholar
• Thimmulappa RK, Lee H, Rangasamy T et al. Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J. Clin. Invest. 116(4), 984–995 (2006).
   Google Scholar
• Chan K, Kan YW. Nrf2 is essential for protection against acute pulmonary injury in mice. Proc. Natl Acad. Sci. USA 96(22), 12731–12736 (1999).
   Google Scholar
• Barajas B, Che N, Yin F et al. NF-E2-related factor 2 promotes atherosclerosis by effects on plasma lipoproteins and cholesterol transport that overshadow antioxidant protection. Arterioscler. Thromb. Vasc. Biol. 31(1), 58–66 (2012).
   Google Scholar
• Freigang S, Ampenberger F, Spohn G et al. Nrf2 is essential for cholesterol crystalinduced inflammasome activation and exacerbation of atherosclerosis. Eur. J. Immunol. 41(7), 2040–2051 (2012).
   Google Scholar
• Sussan TE, Jun J, Thimmulappa R et al. Disruption of Nrf2, a key inducer of antioxidant defenses, attenuates ApoEmediated atherosclerosis in mice. PLoS ONE 3(11), e3791 (2008).
   Google Scholar
• Huang J, Tabbi-Anneni I, Gunda V, Wang L. Transcription factor Nrf2 regulates SHP and lipogenic gene expression in hepatic lipid metabolism. Am. J. Physiol. Gastrointest. Liver Physiol. 299(6), G1211–G1221 (2010).
   Google Scholar
• Ishii T, Itoh K, Ruiz E. Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4‒hydroxynonenal. Circ. Res. 94(5), 609–616 (2004).
   Google Scholar
• Kadl A, Meher AK, Sharma PR et al. Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2. Circ. Res. 107(6), 737–746 (2010).
   Google Scholar
• Khoo NK, Freeman BA. Electrophilic nitro-fatty acids: anti-inflammatory mediators in the vascular compartment. Curr. Opin. Pharmacol. 10(2), 179–184 (2010)
   Google Scholar